The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
Abstract
A dual isotype (IgG, IgA) enzyme-linked immunosorbent assay (ELISA) designed to provide enhanced detection of primary biliary cirrhosis (PBC)-specific autoantibodies against both major mitochondrial and nuclear antigens has been developed and recently become commercially available. The assay (PBC Screen) simultaneously detects IgG and IgA autoantibodies to the immunodominant portions of the 3 major mitochondrial (MIT3) and nuclear (gp210, and sp100) antigens. The aim of this study was to compare the performance of the PBC Screen to the combined performance obtained with individual IgG ELISAs to MIT3, gp210, and sp100 on a large group of selected patients from multiple centers. A total of 1175 patients with PBC and 1232 subjects without PBC were evaluated. Non-PBC groups included healthy controls (624) as well as individuals with autoimmune hepatitis (281), primary sclerosing cholangitis (77), viral hepatitis (91 hepatitis B and 98 hepatitis C), other liver diseases (31), and other infectious or autoimmune diseases (30). The PBC Screen at the receiver operator characteristic optimized cutoff of 27.8 units, had an overall sensitivity of 83.8%, specificity of 94.7% and area under curve of 0.9212. This was similar to the specificity of 96.1% obtained by the combined results of individual MIT3, sp100, and gp210 IgG ELISAs (kappa index at 0.898). Of the 253 PBC patients without AMA detectable by immunofluorescence, 113 (44.7%) were interpreted as positive for PBC-specific autoantibodies. In conclusion, the PBC Screen is an appropriate first-line test for the diagnosis of PBC, including for patients negative for markers assessed using conventional methods.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 5% of patients with PBC are negative for AMA (or anti PDC-E2/M2 by ELISA), although this figure in practice reflects the assays employed.263 264”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [264]
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationKaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,016
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Self-citationLindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
(2015) · Elsevier eBooks · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 808
Krawitt, E. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050408 · Cited by 762
Self-citationStaging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Invernizzi, P., Podda, M., Battezzati, P. M., Crosignani, A., Zuin, M. G., Hitchman, E., Maggioni, M., Meroni, P. L., Penner, E., & Węsierska‐Gądek, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00040-4 · Cited by 454
Self-citationVergani, D., Alvarez, F., Bianchi, F. B., Cançado, E. L. R., Mackay, I. R., Manns, M. P., Nishioka, M., & Penner, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.002 · Cited by 446
Self-citationNakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology · doi:10.1002/hep.21472 · Cited by 365
Self-citationSzostecki, C., Will, H., Netter, H. J., & Guldner, H. H. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb03224.x · Cited by 363
Szostecki, C., Guldner, H. H., Netter, H. J., & Will, H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4338 · Cited by 269
Hirschfield, G. M., & Heathcote, E. J. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch32 · Cited by 261
Self-citationDefinition of human autoimmunity — autoantibodies versus autoimmune disease
Lleò, A., Invernizzi, P., Gao, B., Podda, M., & Gershwin, M. E. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.12.002 · Cited by 249
Self-citationAutoimmune liver serology: Current diagnostic and clinical challenges
Bogdanos, D. P., Invernizzi, P., Mackay, I. R., & Vergani, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3374 · Cited by 213
Self-citationMiyakawa, H., Tanaka, A., Kikuchi, K., Matsushita, M., Kitazawa, E., Kawaguchi, N., Fujikawa, H., & Gershwin, E. M. (2001) · Hepatology · doi:10.1053/jhep.2001.26514 · Cited by 200
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis
Wesierska-Gadek, J., Penner, E., Battezzati, P. M., Selmi, C., Zuin, M., Hitchman, E., Worman, H. J., Gershwin, E. M., Podda, M., & Invernizzi, P. (2006) · Hepatology · doi:10.1002/hep.21172 · Cited by 177
Self-citationOertelt, S., Rieger, R., Selmi, C., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S. C., & Gershwin, E. M. (2007) · Hepatology · doi:10.1002/hep.21583 · Cited by 168
Self-citationMoteki, S., Leung, P. S., Coppel, R. L., Dickson, E. R., Kaplan, M. M., Munoz, S., & Gershwin, M. E. (1996) · Hepatology · doi:10.1002/hep.510240117 · Cited by 152
Self-citationLong-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis
O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., & Heathcote, E. J. (2008) · Hepatology · doi:10.1002/hep.22380 · Cited by 146
Self-citationCourvalin, J., Lassoued, K., Bartnik, E., Blobel, G., & Wozniak, R. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114696 · Cited by 136
Rigopoulou, E. I., Davies, E. T., Pares, A., Zachou, K., Liaskos, C., Bogdanos, D.-P., Rodes, J., Dalekos, G. N., & Vergani, D. (2005) · Gut · doi:10.1136/gut.2003.036558 · Cited by 134
Self-citationInterpreting serological tests in diagnosing autoimmune liver diseases
Invernizzi, P., Lleo, A., & Podda, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979469 · Cited by 107
Self-citationBandin, O., Courvalin, J., Poupon, R. Y., Dubel, L., Homberg, J., & Johanet, C. (1996) · Hepatology · doi:10.1002/hep.510230512 · Cited by 105
Nickowitz, R. E., & Worman, H. J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2237 · Cited by 94
Self-citationAntinuclear Antibodies in Primary Biliary Cirrhosis
Invernizzi, P., Selmi, C., Ranftler, C., Podda, M., & Wȩsierska-Ga̧dek, J. (2005) · Seminars in liver disease (Print) · doi:10.1055/s-2005-916321 · Cited by 87
Self-citationMuratori, P., Muratori, L., Gershwin, M. E., Czaja, A. J., Παππάς, Γ., Maccariello, S., Granito, A., Cassani, F., Loria, P., Lenzi, M., et al. (2003) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02332.x · Cited by 84
Self-citationNishio, A., de Water, J. V., Leung, P. S. C., Joplin, R., Neuberger, J., Lake, J. R., Björkland, A., Tötterman, T. H., Peters, M. G., Worman, H. J., et al. (1997) · Hepatology · doi:10.1002/hep.510250506 · Cited by 77
Self-citationNew ELISA for Detecting Primary Biliary Cirrhosis–Specific Antimitochondrial Antibodies
Dähnrich, C., Parés, A. R., Caballería, L., Rosemann, A., Schlumberger, W., Probst, C., Mytilinaiou, M. G., Bogdanos, D. P., Vergani, D., STÖCKER, W., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118299 · Cited by 75
Self-citationManagement of Primary Sclerosing Cholangitis
Lee, Y., & Kaplan, M. M. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05585.x · Cited by 66
Malmborg, A., Shultz, D. B., Luton, F., Mostov, K. E., Richly, E., Leung, P. S. C., Benson, G. D., Ansari, A. A., Coppel, R. L., Gershwin, M. E., et al. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0220 · Cited by 63
Self-citationGabeta, S., Norman, G., Liaskos, C., Papamichalis, P., Zografos, T., Garagounis, A., Rigopoulou, E., & Dalekos, G. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9092-0 · Cited by 62
Self-citationPresence of antimitochondrial autoantibodies in patients with autoimmune hepatitis
Nezu, S., Tanaka, A., Yasui, H., Imamura, M., Nakajima, H., Ishida, H., & Takahashi, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04434.x · Cited by 52
Immunological Study of Anti-M2 in Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis.
KITAMI, N., KOMADA, T., ISHII, H., Shimizu, H., Adachi, H., Yamaguchi, Y., Kitamura, T., Oide, H., Miyazaki, A., Ishikawa, M., et al. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.496 · Cited by 46
Tartakovsky, F., & Worman, H. J. (1995) · Hepatology · doi:10.1002/hep.1840210234 · Cited by 37
Self-citationBlüthner, M., Schäfer, C., Schneider, C., & Bautz, F. A. (1999) · Autoimmunity · doi:10.3109/08916939908995970 · Cited by 34
Nakajima, M., Shimizu, H., Miyazaki, A., Watanabe, S., KITAMI, N., & Sato, N. (1999) · Journal of Gastroenterology · doi:10.1007/s005350050380 · Cited by 32
Liaskos, C., Bogdanos, D. P., Rigopoulou, E. I., & Dalekos, G. N. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04751.x · Cited by 24
Self-citationThe diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis.
Tanaka, A., Miyakawa, H., Luketic, V. A., Kaplan, M., Storch, W., & Gershwin, M. E. (2002) · PubMed · Cited by 21
Self-citationHarada, K., Sudo, Y., Kono, N., Ozaki, S., Tsuneyama, K., Gershwin, E. M., & Nakanuma, Y. (1999) · Hepatology · doi:10.1002/hep.510300145 · Cited by 21
Kadokawa, Y., Omagari, K., Hazama, H., Ohba, K., Masuda, J.-I., Kinoshita, H., Hayashida, K., Isomoto, H., Mizuta, Y., Murase, K., et al. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00439-3 · Cited by 18
Hazama, H., Omagari, K., MASUDA, J., Ohba, K., KINOSHITA, H., MATSUO, I., Isomoto, H., Mizuta, Y., Murase, K., Murata, I., et al. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02700.x · Cited by 11
Flagged first, then by citations
2 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationHirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Self-citationA randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kowdley, K. V., Luketic, V., Chapman, R., Hirschfield, G. M., Poupon, R., Schramm, C., Vincent, C., Rust, C., Parés, A., Mason, A., et al. (2018) · Hepatology · doi:10.1002/hep.29569 · Cited by 281
Self-citationLleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationEnzyme-Linked Immunosorbent Assay: Types and Applications
Hayrapetyan, H., Tran, T. T., Tellez‐Corrales, E., & Madiraju, C. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2903-1_1 · Cited by 208
Metadata
- Authors
- Liu, H., Norman, G. L., Shums, Z., Worman, H. J., Krawitt, E. L., Bizzaro, N., Vergani, D., Bogdanos, D. P., Dalekos, G. N., Milkiewicz, P., Czaja, A. J., Heathcote, E. J., Hirschfield, G. M., Tan, E. M., Miyachi, K., Bignotto, M., Battezzati, P. M., Lleo, A., Leung, P. S., Podda, M., Gershwin, M. E., & Invernizzi, P.
- Affiliations
- Guangzhou Women and Children Medical Center (CN)
- Columbia University Irving Medical Center (US)
- University of Vermont (US)
- King's College London (GB)
- Pomeranian Medical University (PL)
- Mayo Clinic (US)
- University of Toronto (CA)
- Scripps Research Institute (US)
- University of Milan (IT)
- University of California, Davis (US)
- Corresponding author
- Invernizzi, Pietro
- ORCID
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 35
- Issue
- 4
- Pages
- 436-442
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W1976817326
- Cited by
- 130
- References
- 46
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 11 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 5 · 2014: 8 · 2013: 14 · 2012: 23
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Autoimmunity (publishedVersion)
- PubMed (publishedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoantibody detection, sensitivity and specificity, autoimmune hepatitis, primary sclerosing cholangitis, hepatitis B, hepatitis C, serological diagnosis
- MeSH terms
- Autoantibodies, Autoantigens, Clinical Trials as Topic, Enzyme-Linked Immunosorbent Assay, Feasibility Studies, Humans, Immunoglobulin A, Immunoglobulin G, Liver Cirrhosis, Biliary, Recombinant Fusion Proteins, Sensitivity and Specificity, Reproducibility of Results, Likelihood Functions, Immunodominant Epitopes, Mitochondrial Proteins, Nuclear Pore Complex Proteins, Antigens, Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review